generalized anxiety disorder Archives

Optimal Dose of Exercise for Generalized Anxiety Disorder (GAD) in Aging Adults (2024 Study)

Generalized Anxiety Disorder (GAD), a prevalent condition among older adults, may be significantly influenced by physical activity levels. Recent research from The Irish Longitudinal Study on Ageing (TILDA) provides groundbreaking insights into how even minimal physical activity can reduce the risk of GAD. Highlights: Minimal Dose for Maximum Benefit: Even low levels of moderate-to-vigorous physical …

Medical Cannabis for Generalized Anxiety Disorders & Sleep Disturbances (2023 Study)

by GLOOM

Recent research has shed light on the potential benefits of cannabis-based medicinal products (CBMPs) in treating Generalized Anxiety Disorder (GAD), especially in patients with sleep disturbances. Recent research explored the effectiveness of CBMPs on GAD, the role of sleep quality in treatment outcomes, and the incidence of adverse events. Highlights: CBMPs Show Promise in Treating …

Vortioxetine Efficacy for Major Depression & Comorbid Anxiety (2023 Study)

by GLOOM

The RELIEVE study provides pivotal insights into the effectiveness of vortioxetine in treating patients with Major Depressive Disorder (MDD) co-morbid with Generalized Anxiety Disorder (GAD). A subgroup analysis of the observational study highlights significant improvements in patient functioning, depression severity, cognitive symptoms, and quality of life. The findings underscore vortioxetine’s potential as a beneficial treatment …

Depressed vs. Anxious Brains: Differences in Brain Waves & Connectivity Revealed

by GLOOM

Advanced analysis of multidimensional EEG data reveals significant differences in brain activity patterns between Generalized Anxiety Disorder (GAD) and Depressive Disorder (DD). The distinguishing factors seem to be differences in beta brain waves and functional connectivity between various brain regions. Key Facts: Patients with DD exhibited higher power spectrum density (PSD) values and fuzzy entropy …

Seroquel (Quetiapine) For Anxiety Disorders: An “Atypical” Treatment

by GLOOM

Seroquel (Quetiapine) is an atypical antipsychotic engineered in the early 1990s by the pharmaceutical company AstraZeneca. It was first approved by the FDA in 1997 for the treatment of schizophrenia, and was sequentially approved by the FDA in 2004 for the management of bipolar mania. Seroquel would also receive subsequent FDA approval in 2009 as …

Valerian For Anxiety Disorders

by GLOOM

Valerian (Valeriana officinalis) is a perennial plant named after the Latin term “valere,” which roughly translates to “strong and healthy.” The plant is considered native to Europe and various regions of Asia and tends to bloom pinkish and/or whitish flowers in the summer seasons. Upon blooming, its flowers are universally known to have a sweet, …

Effexor (Venlafaxine) For Anxiety Disorders: An Effective Anxiolytic?

by GLOOM

Effexor (Venlafaxine) is a drug that was introduced in 1993 as a pharmaceutical antidepressant by Wyeth; its marketing rights are now owned by Pfizer. Pharmacodynamically, it functions primarily as a serotonin-norepinephrine reuptake inhibitor (SNRI) and is understood to be the first-ever “dual reuptake inhibitor” approved by the FDA for the treatment of major depressive disorder. …